Table 4.
Covariate | AUC (mg day/L) | B cell count at 2 years (day 728) (cells/µL) | Time to LLN (days) | |
---|---|---|---|---|
Percentiles | Weight (kg) | |||
5th | 50 | 57.2 [17.8–129.1] | 1.1 [0.3–5.8] | 204.0 [82.0–480.0] |
Median | 70 | 33.3 [10.6–76.8] | 1.3 [0.4–7.3] | 164.0 [61.1–425.8] |
95th | 110 | 16.0 [3.4–37.4] | 1.6 [0.5–30.8] | 128.0 [32.9–364.0] |
Age (years) | ||||
Minimum | 18 | 34.4 [11.7–80.1] | 1.6 [0.5–8.6] | 156.0 [52.0–388.4] |
Median | 38 | 34.6 [9.5–78.3] | 1.4 [0.4–9.8] | 160.0 [54.5–412.0] |
Maximum | 56 | 34.4 [10.2–81.8] | 1.2 [0.3–7.1] | 172.0 [70.0–454.4] |
Cell count (cells/µL) | ||||
5th | 80 | 33.0 [11.5–75.9] | 1.6 [0.5–7.7] | 164.0 [58.0–424.0] |
Median | 200 | 34.7 [9.6–76.1] | 1.3 [0.4–8.5] | 164.0 [52.0–422.4] |
95th | 460 | 33.5 [10.8–80.4] | 1.1 [0.3–10.9] | 162.0 [58.0–435.8] |
AUC area under the curve, LLN lower limit of normal (40 cells/µL), PK pharmacokinetic